Previous 10 | Next 10 |
Recro Pharma, Inc. (REPH) Q2 2019 Earnings Conference Call August 8, 2019 08:00 AM ET Company Participants Claudia Styslinger - IR Geraldine Henwood - President & CEO Ryan Lake - CFO Conference Call Participants Leland Gershell - Oppenheimer & Co. Michael Ingerman...
Thinly traded Recro Pharma ( REPH +16.9% ) is up on below-average volume in early trade after its Q2 report released this morning. Highlights: More news on: Recro Pharma, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
The following slide deck was published by Recro Pharma, Inc. in conjunction with their 2019 Q2 earnings Read more ...
Recro Pharma (NASDAQ: REPH ): Q2 GAAP EPS of -$0.13 beats by $0.29 . More news on: Recro Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Record Results and Raising Guidance Announces Plan to Spin Acute Care Company to Host Conference Call Today at 8:00 AM ET MALVERN, Pa., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a pharmaceutical company with a high-performing, revenue generating contra...
MALVERN, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a pharmaceutical company with a high-performing, revenue generating contract development and manufacturing (CDMO) segment and an Acute Care segment, today announced that it will report second quarter financial...
MALVERN, Pa., May 30, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a pharma company with a high-performing, revenue generating contract development and manufacturing (CDMO) segment and an Acute Care segment, today announced that Gerri Henwood, the Company’s President an...
Recro Pharma, Inc. (REPH) Q1 2019 Earnings Conference Call May 10, 2019 08:00 ET Company Participants Claudia Styslinger - IR Geraldine Henwood - President & CEO Ryan Lake - CFO Conference Call Participants Leland Gershell - Oppenheimer & Co. David Amsellem - Pipe...
Recro Pharma ( REPH ) Q1 results : Revenues: $25.1M (+28.7%). More news on: Recro Pharma, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
Recro Pharma (NASDAQ: REPH ): Q1 GAAP EPS of -$0.10. More news on: Recro Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to Commence a Tender Offer for all Outstanding Shares of Societal CDMO, Inc. CLEARWATE...
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing through Process Development and cGMP Manufacturing to Fill/Finish GAINESVILLE, Ga. ...
Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated Corporate Restructuring; Expected to Result in Annualized Savings of Approxi...